Employees: 12 (2023.0)Legal category: 5785Size: PMECreation date: 2003-01-01 (23 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13013), Bouches-du-Rhone
PHARMACIE DE LA MARIE : revenue, balance sheet and financial ratios
PHARMACIE DE LA MARIE is a French company
founded 23 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13013),
this company of category PME
shows in 2023 a revenue of 6.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA MARIE (SIREN 448680132)
Indicator
2024
2023
2021
2020
2019
2017
2016
Revenue
N/C
6 737 143 €
4 210 970 €
4 416 131 €
4 491 306 €
3 646 113 €
3 176 600 €
Net income
589 294 €
363 440 €
-721 905 €
56 341 €
63 875 €
100 931 €
74 536 €
EBITDA
N/C
402 413 €
4 210 970 €
202 411 €
121 908 €
121 823 €
134 633 €
Net margin
N/C
5.4%
-17.1%
1.3%
1.4%
2.8%
2.3%
Revenue and income statement
In 2024, PHARMACIE DE LA MARIE generates positive net income of 589 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 75 k€ -> 589 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
589 294 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 68%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 29%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
67.556%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
28.911%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA MARIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2019
2020
2021
2023
2024
Debt ratio
37.96
31.919
35.874
28.077
-236.222
81.209
67.556
Financial autonomy
47.532
43.001
38.219
37.018
-20.859
21.556
28.911
Repayment capacity
1.981
4.692
0.696
2.399
4.018
0.771
None
Cash flow / Revenue
3.03%
0.773%
2.028%
1.608%
2.586%
5.886%
None%
Sector positioning
Debt ratio
67.562024
2021
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average+27 pts over 3 years
In 2024, the debt ratio of PHARMACIE DE LA MARIE (67.56) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
28.91%2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of PHARMACIE DE LA MARIE (28.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
0.77 years2023
2021
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Excellent-28 pts over 2 years
In 2023, the repayment capacity of PHARMACIE DE LA MARIE (0.77) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 162.05. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
162.049
Liquidity indicators evolution PHARMACIE DE LA MARIE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2019
2020
2021
2023
2024
Liquidity ratio
61.994
53.193
55.454
61.62
84.75
130.097
162.049
Interest coverage
8.924
5.872
4.141
1.896
0.112
1.256
None
Sector positioning
Liquidity ratio
162.052024
2021
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average+24 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE LA MARIE (162.05) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
1.26x2023
2021
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average+9 pts over 2 years
In 2023, the interest coverage of PHARMACIE DE LA MARIE (1.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA MARIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2019
2020
2021
2023
2024
Operating WCR
214 325 €
207 136 €
291 531 €
60 722 €
92 347 €
931 343 €
0 €
Inventory turnover (days)
18
17
12
13
5
15
0
Customer payment term (days)
18
17
34
22
35
49
0
Supplier payment term (days)
53
58
59
63
836
57
0
Positioning of PHARMACIE DE LA MARIE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LA MARIE is estimated at
8 226 979 €
(range 5 729 138€ - 12 308 032€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
5729k€8226k€12308k€
8 226 979 €Range: 5 729 138€ - 12 308 032€
NAF 5 année 2024
Valuation method used
Net Income Multiple
589 294 €
×
14.0x
=8 226 980 €
Range: 5 729 139€ - 12 308 033€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA MARIE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA MARIE
What is the revenue of PHARMACIE DE LA MARIE ?
The revenue of PHARMACIE DE LA MARIE in 2023 is 6.7 M€.
Is PHARMACIE DE LA MARIE profitable?
Yes, PHARMACIE DE LA MARIE generated a net profit of 589 k€ in 2024.
Where is the headquarters of PHARMACIE DE LA MARIE ?
The headquarters of PHARMACIE DE LA MARIE is located in MARSEILLE (13013), in the department Bouches-du-Rhone.
Where to find the tax return of PHARMACIE DE LA MARIE ?
The tax return of PHARMACIE DE LA MARIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA MARIE operate?
PHARMACIE DE LA MARIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart